2nd Retinoblastoma Tumor Suppressor Symposium - Toronto 2011

第二届视网膜母细胞瘤肿瘤抑制研讨会 - 多伦多 2011

• 批准号: 208454
• 负责人: Bremner Rod
• 金额: $ 1.46万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Miscellaneous Programs
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-06-01 至 2011-06-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=208454&lang=en
• 关键词: Cancer; Cyclin/Cdk; E2f; Rb Pathway; Skp2

The retinoblastoma tumor suppressor, RB, is inactivated in most human malignancies and is one of the most important and well-studied tumor suppressors. Recent progress in Canada and around the world has revealed new insights into the mechanisms by which R

视网膜母细胞瘤肿瘤抑制因子RB在大多数人类恶性肿瘤中是失活的，并且是最重要和充分研究的肿瘤抑制因子之一。加拿大和世界各地的最新进展揭示了对R